'ArthronPulse', an electroceutical to treat arthritis that goes beyond pharmaceuticals
Entwick's first electrotherapeutic treatment is ArtheonPluse, an electroceutical for degenerative arthritis that utilizes ELF-EMF and LLL treatment technologies. Many studies have reported that ELF-EMF inhibits the expression of pro-arthritic factors and increases cartilage matrix-enhancing factors, while LLL improves joint pain.
ArtheonPulse, Entwick’s electroceutical for treating arthritis, is a cordless, wearable form of low-power, far-field magnetic transfer technology and three-wavelength, low-level laser therapy. It is a medical homecare product with a form factor for mobility that enables low-cost, consistent joint care.